![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SEPRACOR ANNOUNCES PARTNERSHIP WITH ACADIA PHARMACEUTICALS
SEPRACOR ANNOUNCES PARTNERSHIP WITH ACADIA PHARMACEUTICALS
Sepracor has announced the formation of a partnership with Acadia Pharmaceuticals for development of new drug candidates targeted toward treatment of central nervous system (CNS) disorders. This research and development collaboration has been established to investigate potential clinical candidates resulting from Acadia's extensive medicinal chemistry and discovery platform against a broad array of selective muscarinic receptors (receptors that respond to acetylcholine, a neurotransmitter in the central nervous system).
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18654220&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct